Literature DB >> 18674700

Gastric cancer: pathogenesis, screening, and treatment.

Kentaro Sugano1.   

Abstract

Early gastric cancer is a curable disease regardless of its location, histologic type, genetic changes, or the ethnicity of the patient. To improve the detection rate of early gastric cancer, intensive training of endoscopists and the use of novel endoscopic techniques have been introduced into routine examinations in Japan. In the United States, where most gastric cancer is found in advanced stages, a similar approach should be advocated. Endoscopic resection of high-grade dysplasia is also encouraged in the United States not only for proper diagnosis but also for achieving cure without surgical intervention.

Entities:  

Mesh:

Year:  2008        PMID: 18674700     DOI: 10.1016/j.giec.2008.05.003

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  12 in total

Review 1.  The prevention of infection-associated cancers.

Authors:  Silvio De Flora; Paolo Bonanni
Journal:  Carcinogenesis       Date:  2011-03-24       Impact factor: 4.944

2.  Active Stat3 and Her-2 as combined survival predictors show superiority to TNM staging system for postoperative patients with gastric cancer.

Authors:  Ke Sun; Meng Qing Xu; Hai Jun Zhang; Dan Dan Zhang; Wen Yue; Miao Miao Ma; Lin Tao; Wen Jie Zhang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

3.  Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer.

Authors:  Wei-Qing Xu; Ling-Jun Song; Qiang Liu; Lei Zhao; Lin Zheng; Zhao-Wen Yan; Guo-Hui Fu
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-28       Impact factor: 4.553

4.  Metastatic gastric cancer - focus on targeted therapies.

Authors:  Judith Meza-Junco; Michael B Sawyer
Journal:  Biologics       Date:  2012-06-20

5.  Critical appraisal of trastuzumab in treatment of advanced stomach cancer.

Authors:  Judith Meza-Junco; Heather-Jane Au; Michael B Sawyer
Journal:  Cancer Manag Res       Date:  2011-03-03       Impact factor: 3.989

6.  Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.

Authors:  C C Abnet; W Zheng; W Ye; F Kamangar; B-T Ji; C Persson; G Yang; H-L Li; N Rothman; X-O Shu; Y-T Gao; W-H Chow
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

7.  Training in early gastric cancer diagnosis improves the detection rate of early gastric cancer: an observational study in China.

Authors:  Qiang Zhang; Zhen-Yu Chen; Chu-di Chen; Tao Liu; Xiao-Wei Tang; Yu-Tang Ren; Si-Lin Huang; Xiao-Bing Cui; Sheng-Li An; Bing Xiao; Yang Bai; Si-de Liu; Bo Jiang; Fa-Chao Zhi; Wei Gong
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

8.  Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections.

Authors:  Renato Santos Laboissiere; Marcelo Araújo Buzelin; Débora Balabram; Marina De Brot; Cristiana Buzelin Nunes; Rafael Malagoli Rocha; Mônica Maria Demas Álvares Cabral; Helenice Gobbi
Journal:  BMC Gastroenterol       Date:  2015-11-04       Impact factor: 3.067

9.  Molecular targeted agents for gastric cancer: a step forward towards personalized therapy.

Authors:  Esther Una Cidon; Sara G Ellis; Yasir Inam; Sola Adeleke; Sara Zarif; Tom Geldart
Journal:  Cancers (Basel)       Date:  2013-01-21       Impact factor: 6.639

10.  Gastric cardia adenocarcinoma pathway analysis.

Authors:  Hakimeh Zali; Mostafa Rezaei-Tavirani; Reza Vafaee; Majid Rezaei-Tavirani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.